PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 3, 2024International Journal of Dermatology3 citations

Oral fusidic acid for the treatment of mild‐to‐moderate hidradenitis suppurativa

View Full Paper
AWAntonia WialaUniversity Clinic of TraumatologySDSophie M. DaschlUniversity Clinic of TraumatologyTSTheresa StockingerBrooke Army Medical Center

Key Points

Key points are not available for this paper at this time.

Abstract

Hidradenitis suppurativa (HS) is a debilitating inflammatory skin disease. Tetracyclines are one of the few therapeutic options recommended for mild-to-moderate disease. This study aimed to investigate the efficacy of systemic fusidic acid's (FA) effectiveness in treating HS.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wiala et al. (2024) studied this question.

synapsesocial.com/papers/68e75ef7b6db6435876d5ccahttps://doi.org/10.1111/ijd.17115
Ask AI
Helpful
Bookmark
Share
View Full Paper